AcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023

HAYWARD, Calif., July 27, 2023 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will release…

Click here to view original post